EP1124985A4 - Biomarker für oxidativen stress - Google Patents

Biomarker für oxidativen stress

Info

Publication number
EP1124985A4
EP1124985A4 EP99971864A EP99971864A EP1124985A4 EP 1124985 A4 EP1124985 A4 EP 1124985A4 EP 99971864 A EP99971864 A EP 99971864A EP 99971864 A EP99971864 A EP 99971864A EP 1124985 A4 EP1124985 A4 EP 1124985A4
Authority
EP
European Patent Office
Prior art keywords
oxidation stress
stress biomarkers
biomarkers
oxidation
stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP99971864A
Other languages
English (en)
French (fr)
Other versions
EP1124985A1 (de
Inventor
Joseph M Kinkade Jr
Raymond Shapira
Peter E Jensen
Ngoc-Anh Le
Jan Pohl
W Virgil Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of EP1124985A1 publication Critical patent/EP1124985A1/de
Publication of EP1124985A4 publication Critical patent/EP1124985A4/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
EP99971864A 1998-11-06 1999-11-05 Biomarker für oxidativen stress Ceased EP1124985A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10740498P 1998-11-06 1998-11-06
US107404P 1998-11-06
PCT/US1999/026133 WO2000028072A1 (en) 1998-11-06 1999-11-05 Biomarkers for oxidative stress

Publications (2)

Publication Number Publication Date
EP1124985A1 EP1124985A1 (de) 2001-08-22
EP1124985A4 true EP1124985A4 (de) 2003-01-15

Family

ID=22316499

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99971864A Ceased EP1124985A4 (de) 1998-11-06 1999-11-05 Biomarker für oxidativen stress

Country Status (4)

Country Link
EP (1) EP1124985A4 (de)
AU (1) AU1243500A (de)
CA (1) CA2348685A1 (de)
WO (1) WO2000028072A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040029208A1 (en) * 2000-05-30 2004-02-12 Ravn Helle Weber Assay method and kit for testing biological material for exposure to stress using biomarkers
DE10051983A1 (de) 2000-10-20 2002-06-13 Beate Kehrel Inhibierung der pathogenen Wirkung oxidierter Proteine
EP1994941A3 (de) * 2000-10-20 2012-07-25 Hamburger Stiftung zur Förderung von Wissenschaft und Kultur Arzneimittel, enthaltend mindestens ein oxidiertes Protein
AU2003232872A1 (en) 2002-05-27 2003-12-12 Ostergotlands Lans Landsting Method for determining immune system affecting compounds
GB0329288D0 (en) 2003-12-18 2004-01-21 Inverness Medical Switzerland Monitoring method and apparatus
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
EP1875246B1 (de) 2005-04-15 2016-10-05 CanImGuide Therapeutics AB Diagnoseverfahren zum nachweis von krebs durch messen der menge eines cytokinähnlichen il-6
ES2608803T3 (es) 2007-05-08 2017-04-17 Canimguide Therapeutics Ab Estructuras inmunorreguladoras procedentes de proteínas naturales
JP2010183843A (ja) * 2009-02-10 2010-08-26 National Institute Of Advanced Industrial Science & Technology 含硫アミノ酸残基が酸化された酸化型ポリペプチドに対する抗体
WO2012018535A2 (en) 2010-07-26 2012-02-09 Wellness Indicators, Inc. Wellness panel
WO2014201451A1 (en) * 2013-06-14 2014-12-18 Wellmetris Llc Stress and inflammation biomarker urine panel for dairy cows and beef cattle
CA2832215A1 (en) 2013-07-18 2015-01-18 Northern Sydney Local Health District Biomarkers of oxidative stress

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004311A1 (en) * 1994-08-03 1996-02-15 University Of Alabama At Birmingham Research Foundation Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease
WO1997011371A1 (en) * 1995-09-19 1997-03-27 Cytochem, Inc. Detection and quantitation of 8-oh-adenine using monoclonal antibodies
WO1998012561A1 (en) * 1996-09-20 1998-03-26 Atherogenics, Inc. Diagnostics for and mediators of inflammatory disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859613A (en) * 1986-11-12 1989-08-22 Lawrence David A Immunoassays for glutathione and antibodies useful therein
US5508031A (en) * 1986-11-21 1996-04-16 Cetus Oncology Corporation Method for treating biological damage using a free-radial scavenger and interleukin-2
WO1992022668A1 (en) * 1991-06-14 1992-12-23 Vanderbilt University Method and compositions to assess oxidative stress in vivo
KR100300932B1 (ko) * 1992-07-06 2001-10-22 조이스 브린톤 리포터유전자에융합된세균의스트레스프로모터를이용하여독성을측정하는방법및진단키트
US5605826A (en) * 1994-06-10 1997-02-25 Panorama Research, Inc. 24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis
US5814300A (en) * 1995-03-03 1998-09-29 Cephalon, Inc. Gene-targeted non-human mammals deficient in the SOD-1 gene

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004311A1 (en) * 1994-08-03 1996-02-15 University Of Alabama At Birmingham Research Foundation Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease
WO1997011371A1 (en) * 1995-09-19 1997-03-27 Cytochem, Inc. Detection and quantitation of 8-oh-adenine using monoclonal antibodies
WO1998012561A1 (en) * 1996-09-20 1998-03-26 Atherogenics, Inc. Diagnostics for and mediators of inflammatory disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AHMAD J ET AL: "DETECTION OF OXIDATIVE DNA DAMAGE BY A MONOCLONAL ANTIBODY: ROLE OF LYSYL RESIDUES IN ANTIGEN BINDING", IMMUNOLOGY LETTERS, AMSTERDAM, NL, vol. 62, no. 2, June 1998 (1998-06-01), pages 87 - 92, XP001118007, ISSN: 0165-2478 *
See also references of WO0028072A1 *

Also Published As

Publication number Publication date
AU1243500A (en) 2000-05-29
WO2000028072A1 (en) 2000-05-18
CA2348685A1 (en) 2000-05-18
WO2000028072A9 (en) 2000-09-21
EP1124985A1 (de) 2001-08-22

Similar Documents

Publication Publication Date Title
EP0939672A4 (de) Katalysator zur teiloxidation
DK0970386T3 (da) Impedans-til-spænding-konverter
DK0973012T3 (da) Transducer
NO991944D0 (no) Ny forbindelse
PT1119430E (pt) Fresa
DE69707764D1 (de) Cumol-Oxydationsverfahren
NO20003996D0 (no) Ny forbindelse
DE69934464D1 (de) Gleichstromwandler
EP1124985A4 (de) Biomarker für oxidativen stress
DE69925438D1 (de) Greifer
DE59902764D1 (de) Antriebsrolle
DE69919457D1 (de) Messtaster
DE69903507D1 (de) Beizvorrichtung
DE59913572D1 (de) Gleichspannungswandler
ID27962A (id) Pembuatan tetrahidrofuran
DE69926606D1 (de) Plazentaprotein 13
DE69901764D1 (de) Beizvorrichtung
DE69837290D1 (de) Wagenkasten
DE69917374D1 (de) Wegaufnehmer
EA200000263A1 (ru) Пьезопреобразователь
FR2779445B1 (fr) Kit d'encapsidation
NO20005551D0 (no) 2"-deoksyhygromycinderivater
ID26655A (id) Pembuatan streptokokus
EP1095060A4 (de) Galektin 11
ID26832A (id) Pembuatan laktam

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010606

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20021204

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12Q 1/68 A, 7C 07C 61/06 B, 7C 12N 1/21 B, 7C 12N 9/64 B, 7G 01N 33/68 B

17Q First examination report despatched

Effective date: 20050906

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20090607